| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |